Literature DB >> 15247752

Sexual function after highly selective embolization of cavernous artery in patients with high flow priapism: long-term followup.

Gianfranco Savoca1, Francesco Pietropaolo, Francesco Scieri, Michele Bertolotto, Fabio Pozzi Mucelli, Emanuele Belgrano.   

Abstract

PURPOSE: We present 15 cases of high flow priapism treated by selective embolization and evaluate erectile function at long-term followup.
MATERIALS AND METHODS: Between 1995 and 2001, 15 patients underwent highly selective embolization of the cavernous artery for high flow priapism. Trauma was reported by 12 of the 15 patients, and no etiologic causes were evident in the other 3. The fistula was unilateral in 13 patients and bilateral in 2. All patients underwent embolization during arteriography. Erectile function was determined using the International Index of Erectile Function (IIEF) at followup after an average of 55 months (range 18 to 93).
RESULTS: Postoperative color Doppler ultrasonography showed no recurrence in 11 patients (73%). Repeat pelvic angiography with selective embolization was required at 1 month postoperatively in 3 patients (20%). In 1 case (7%) 3 consecutive embolizations were not conclusive and a surgical operation was required. The IIEF results showed that sexual function was in the normal range in 80% of patients. Three patients (20%) reported a slight change in the quality of erection. Mean postoperative IIEF score was 26.3 (range 18 to 30).
CONCLUSIONS: Highly selective embolization of the fistula is an effective and safe treatment option for high flow priapism because it ensures a high level of preservation of pretreatment erectile function.

Entities:  

Mesh:

Year:  2004        PMID: 15247752     DOI: 10.1097/01.ju.0000132494.44596.33

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

Review 1.  Evaluation and management of priapism: 2009 update.

Authors:  Yun-Ching Huang; Ahmed M Harraz; Alan W Shindel; Tom F Lue
Journal:  Nat Rev Urol       Date:  2009-05       Impact factor: 14.432

2.  [Superselective transarterial coil embolization for therapy of high-flow priapism: a case report].

Authors:  K I Ringe; S Waalkes; T Herrmann; M Galanski; H Rosenthal
Journal:  Urologe A       Date:  2010-06       Impact factor: 0.639

Review 3.  Embolization Treatment of High-Flow Priapism.

Authors:  Kyung Rae Kim
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

Review 4.  Imaging of penile traumas--therapeutic implications.

Authors:  Michele Bertolotto; Loretta Calderan; Maria Assunta Cova
Journal:  Eur Radiol       Date:  2005-08-26       Impact factor: 5.315

5.  [Diagnosis and management of priapism].

Authors:  A Kaminsky; H Sperling
Journal:  Urologe A       Date:  2015-05       Impact factor: 0.639

6.  Recurrent idiopathic high-flow priapism treated with selective arterial embolization after repeated initial treatments for low-flow priapism.

Authors:  Christopher J D Wallis; Nathan Hoag; Peter J Pommerville; Michael E Huk
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

7.  Ethylene-vinyl alcohol copolymer (Onyx(®)) transarterial embolization for post-traumatic high-flow priapism.

Authors:  Olivier Chevallier; Sophie Gehin; Alain Foahom-Kamwa; Pierre Pottecher; Sylvain Favelier; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2016-06

8.  Resistant pediatric priapism: A real challenge for the urologist.

Authors:  Cagri Akin Sekerci; Cem Akbal; Tarik Emre Sener; Ahmet Sahan; Bahadir Sahin; Feyyaz Baltacioglu; Ferruh Simsek
Journal:  Can Urol Assoc J       Date:  2015-08-10       Impact factor: 1.862

9.  Post traumatic prepubertal high-flow priapism: a rare occurrence.

Authors:  Eric Chung; John McKnight; Bruce Hosken
Journal:  Pediatr Surg Int       Date:  2007-05-15       Impact factor: 1.827

Review 10.  Cycling Trauma as a Cause of Arterial Priapism in Children and Teenagers.

Authors:  Aldo Franco De Rose; Irene Paraboschi; Guglielmo Mantica; Alexander Szpytko; Hilgard Ackermann; Giovanni De Caro; Carlo Terrone; Girolamo Mattioli
Journal:  Rev Urol       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.